SCHEMBL4886573

SCHEMBL4886573

COc1c(Cl)cc(Cl)cc1B(c1cc(Cl)cc(Cl)c1OC)c1cc(Cl)cc(Cl)c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 2/20 0.35
TPMT P51580 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29957013 0.85 KMT2A (0.42) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL54507 0.81 KMT2A (0.47) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL4889415 0.78 CYP1A2 (0.43) ALDH1A1HSD17B10TSHRCYP1A2CYP2D6
Ethylene SCHEMBL28106925 0.77 KMT2A (0.44) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
Benzene SCHEMBL29202175 0.77 KMT2A (0.50) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL6079187 0.76 GAA (0.43) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL30261672 0.76 GAA (0.43) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL10510118 0.73 MAPT (0.50) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL23409566 0.71 KMT2A (0.45) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10
SCHEMBL9332735 0.71 TPMT (0.58) KMT2AALDH1A1KDM4EL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817318-B1 STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS NIPPON CATALYTIC CHEM IND (JP) 2013-08-28 EP disclosed
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds AR, AHR, BCL6 KMT2A 1263/4885ALDH1A1 1928/4885KDM4E 2314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.